Trinity Biotech, the Irish-founded medical diagnostics company, has agreed a deal to sell its life sciences supply business to Biosynth for $30 million .
The Nasdaq-listed firm said the deal for its Fitzgerald Industries businesses, is expected to close by the end of the month. Bray-headquartered Trinity develops, manufactures and markets diagnostic systems for the point-of-care and clinical laboratory segments of the diagnostic market. Its products are sold in more than 110 countries, and ...
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오: